Search Results - "Michiaki Fukui"

Refine Results
  1. 1

    Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study by Okamura, Takuro, Hashimoto, Yoshitaka, Hamaguchi, Masahide, Obora, Akihiro, Kojima, Takao, Fukui, Michiaki

    Published in International Journal of Obesity (01-01-2019)
    “…Objectives Obesity is a risk factor for type 2 diabetes mellitus. Among obesity, visceral fat obesity, and ectopic fat obesity, it has been unclear which has…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study by Kojima, Takao, Obora, Akihiro, Hamaguchi, Masahide, Hashimoto, Yoshitaka, Kitae, Aya, Fukui, Michiaki

    “…Background. The triglyceride and glucose index (TyG), defined as the product of triglycerides (TG) and fasting plasma glucose (FPG), is reported as a surrogate…”
    Get full text
    Journal Article
  4. 4

    Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10 by Yuge, Hiroki, Okada, Hiroshi, Hamaguchi, Masahide, Kurogi, Kazushiro, Murata, Hiroaki, Ito, Masato, Fukui, Michiaki

    Published in Cardiovascular diabetology (08-11-2023)
    “…BackgroundPrevious studies have investigated the association between the ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C) and the…”
    Get full text
    Journal Article
  5. 5

    Protocol of efficacy of bifidobacteria intake on gastrointestinal symptoms in symptomatic type 2 diabetes mellitus patients in abdominis: An open-label, randomized controlled trial (Binary STAR study) by Hashimoto, Yoshitaka, Kobayashi, Genki, Kitagawa, Noriyuki, Okada, Hiroshi, Hamaguchi, Masahide, Fukui, Michiaki

    Published in PloS one (11-01-2024)
    “…This randomized, parallel-group study aims to investigate the effects of the probiotic Bifidobacterium bifidum G9-1 (BBG9-1) on the symptoms of diarrhea or…”
    Get full text
    Journal Article
  6. 6

    The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals by Fukuda, Takuya, Hamaguchi, Masahide, Kojima, Takao, Hashimoto, Yoshitaka, Ohbora, Akihiro, Kato, Takahiro, Nakamura, Naoto, Fukui, Michiaki

    Published in Liver international (01-02-2016)
    “…Background & Aims The aim of this study was to evaluate the impact of non‐alcoholic fatty liver disease (NAFLD) on incident type 2 diabetes mellitus (T2DM) in…”
    Get full text
    Journal Article
  7. 7

    Association between alcohol consumption and incidence of type 2 diabetes in middle-aged Japanese from Panasonic cohort study 12 by Takahashi, Fuyuko, Okada, Hiroshi, Hashimoto, Yoshitaka, Kurogi, Kazushiro, Murata, Hiroaki, Ito, Masato, Fukui, Michiaki

    Published in Scientific reports (02-09-2024)
    “…This retrospective cohort study aimed to investigate the association between alcohol consumption and the onset of type 2 diabetes in middle-aged Japanese…”
    Get full text
    Journal Article
  8. 8

    The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes by Hashimoto, Yoshitaka, Osaka, Takafumi, Fukuda, Takuya, Tanaka, Muhei, Yamazaki, Masahiro, Fukui, Michiaki

    Published in Endocrine Journal (2016)
    “…Recent cross-sectional studies revealed that sarcopenia is associated with non-alcoholic fatty liver disease (NAFLD) in general population. However, it remains…”
    Get full text
    Journal Article
  9. 9

    Relationship between metabolic syndrome and trunk muscle quality as well as quantity evaluated by computed tomography by Tanaka, Muhei, Okada, Hiroshi, Hashimoto, Yoshitaka, Kumagai, Muneaki, Nishimura, Hiromi, Oda, Yohei, Fukui, Michiaki

    Published in Clinical nutrition (Edinburgh, Scotland) (01-06-2020)
    “…Metabolic syndrome is a cluster of metabolic abnormalities. Skeletal muscle attenuation and area evaluated by computer tomography (CT) may provide valuable…”
    Get full text
    Journal Article
  10. 10

    Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study by Fukuda, Yukiko, Hashimoto, Yoshitaka, Hamaguchi, Masahide, Fukuda, Takuya, Nakamura, Naoto, Ohbora, Akihiro, Kato, Takahiro, Kojima, Takao, Fukui, Michiaki

    Published in Liver international (01-05-2016)
    “…Background Triglycerides (TG) to high‐density lipoprotein cholesterol (HDL‐C) ratio (TG/HDL‐C) has been recommended for surrogates of insulin resistance…”
    Get full text
    Journal Article
  11. 11

    The modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study by Hashimoto, Yoshitaka, Hamaguchi, Masahide, Kojima, Takao, Ohshima, Yasuhiro, Ohbora, Akihiro, Kato, Takahiro, Nakamura, Naoto, Fukui, Michiaki

    Published in Journal of gastroenterology and hepatology (01-03-2015)
    “…Background and Aim Recent cross‐sectional studies have been reported the possibility that light to moderate alcohol consumption might be negatively associated…”
    Get full text
    Journal Article
  12. 12

    Fermented soybean foods and diabetes by Hashimoto, Yoshitaka, Hamaguchi, Masahide, Fukui, Michiaki

    Published in Journal of diabetes investigation (01-12-2023)
    “…The number of patients with type 2 diabetes mellitus is increasing, and its prevention and management are important. One of the factors contributing to the…”
    Get full text
    Journal Article
  13. 13

    The role of chicken eggs in modulating sarcopenic obesity and gut microbiota in db/db mice by Okamura, Takuro, Hasegawa, Yuka, Hamaguchi, Masahide, Sasano, Ryoichi, Fukui, Michiaki

    Published in Frontiers in microbiology (19-10-2023)
    “…BackgroundSarcopenia obesity, in which loss of muscle mass and fat accumulation occur simultaneously, is the pathological basis of type 2 diabetes mellitus…”
    Get full text
    Journal Article
  14. 14

    Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion by Minami, Yoshito, Hoshino, Atsushi, Higuchi, Yusuke, Hamaguchi, Masahide, Kaneko, Yusaku, Kirita, Yuhei, Taminishi, Shunta, Nishiji, Toshiyuki, Taruno, Akiyuki, Fukui, Michiaki, Arany, Zoltan, Matoba, Satoaki

    Published in Nature communications (13-07-2023)
    “…Nonalcoholic steatohepatitis (NASH) is a progressive disorder with aberrant lipid accumulation and subsequent inflammatory and profibrotic response…”
    Get full text
    Journal Article
  15. 15

    Association between sleep disorder and quality of life in patients with type 2 diabetes: a cross-sectional study by Hashimoto, Yoshitaka, Sakai, Ryosuke, Ikeda, Kenichiro, Fukui, Michiaki

    Published in BMC endocrine disorders (30-06-2020)
    “…We investigated the association between sleep symptoms, which cause sleep disorder, and quality of life (QoL) among people with type 2 diabetes (T2D). In this…”
    Get full text
    Journal Article
  16. 16

    Creatinine‐to‐bodyweight ratio is a predictor of incident non‐alcoholic fatty liver disease: A population‐based longitudinal study by Okamura, Takuro, Hashimoto, Yoshitaka, Hamaguchi, Masahide, Obora, Akihiro, Kojima, Takao, Fukui, Michiaki

    Published in Hepatology research (01-01-2020)
    “…Aim Serum creatinine (Cre) is used as a surrogate marker of muscle mass. We investigated the impact of the Cre‐to‐bodyweight (BW) ratio (Cre/BW) on incident…”
    Get full text
    Journal Article
  17. 17

    Low-attenuation muscle is a predictor of diabetes mellitus: A population-based cohort study by Tanaka, Muhei, Okada, Hiroshi, Hashimoto, Yoshitaka, Kumagai, Muneaki, Nishimura, Hiromi, Fukui, Michiaki

    “…Diabetes mellitus is a major global public health issue. Cross-sectional studies have demonstrated that skeletal muscle quality and quantity by computed…”
    Get full text
    Journal Article
  18. 18

    Metabolic associated fatty liver disease is a risk factor for chronic kidney disease by Hashimoto, Yoshitaka, Hamaguchi, Masahide, Okamura, Takuro, Nakanishi, Naoko, Obora, Akihiro, Kojima, Takao, Fukui, Michiaki

    Published in Journal of diabetes investigation (01-02-2022)
    “…ABSTRACT Background and Aims To clarify the relationship between metabolic dysfunction‐associated fatty liver disease (MAFLD) and chronic kidney disease (CKD)…”
    Get full text
    Journal Article
  19. 19

    Metabolically healthy obesity and risk of incident CKD by Hashimoto, Yoshitaka, Tanaka, Muhei, Okada, Hiroshi, Senmaru, Takafumi, Hamaguchi, Masahide, Asano, Mai, Yamazaki, Masahiro, Oda, Yohei, Hasegawa, Goji, Toda, Hitoshi, Nakamura, Naoto, Fukui, Michiaki

    “…Metabolically healthy obesity (MHO) is a unique obesity phenotype that apparently protects people from the metabolic complications of obesity. The association…”
    Get full text
    Journal Article
  20. 20

    A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men by Nakanishi, Naoko, Hashimoto, Yoshitaka, Okamura, Takuro, Ohbora, Akihiro, Kojima, Takao, Hamaguchi, Masahide, Fukui, Michiaki

    Published in Scientific reports (07-10-2021)
    “…The importance of maintaining the remission of nonalcoholic fatty liver disease (NAFLD) has been overlooked. Here we aimed to clarify factors causing NAFLD…”
    Get full text
    Journal Article